Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) requiring high enantiomeric purity. Its protected amine group and tertiary amine functionality make it valuable in asymmetric synthesis and catalysis. Commonly employed in the preparation of protease inhibitors, kinase inhibitors, and other bioactive molecules in medicinal chemistry. The BOC-protected pyrrolidine structure allows for selective deprotection and further functionalization, enabling efficient route design in drug discovery and process development.